ChemoPro
Critical Care Nutrition that supports Chemo-Therapeutic Treatment
HIGH PROTEIN FORMULA
- Enhanced amino acid pool provides high energy and avoids fatigue.
- Helps control muscle loss and improve skeletal strength, bones and other systems & structures in the body.
- Helps minimize the burdens on the digestion and absorption system due to chemotherapy and radiation treatments.
CAPSAICIN
- Inhibits the growth of cancer cells by activating the olfactory receptors on the tumor cells.
- Slows down the cell division process of the malignant cells leading to death of carcinogenic cells.
- Do not harm the healthy or normal cells surrounding the tumor.
PIPERINE
- Anti-proliferative and anti-metastatic effects on cancer cells.
- Can reverse multi-drug resistance in cancer cells and acts as bio-availability enhancer for many chemotherapeutic agents.
CALORIFIC DISTRIBUTION
ELLAGIC ACID
- Prevents the binding of carcinogens to cellular DNA and kills cancer cells.
- Serves in scavenging and clearing of highly destructive O2 free radicals.
- Induces apoptosis(programmed natural cell death) in cancerous cells.
Provexia is available in Vanilla & Chocolate flavours
| Calories / 30g (one serving) | Calories / 100g |
| 112 Kcal | 374 Kcal |
BENEFITS
- Counterbalance Malnutrition due to hospitalized conditions
- Improve the immune system to fight infections
- Faster recovery and healing from all post-surgical conditions
REFERENCES
- Nutrient requirements and recommended dietary allowances for Indians – Indian Council of Medical Research 2009
- Schaafsma G (July 2000). “The protein digestibility-corrected amino acid score”. The Journal of Nutrition 130 (7): 1865S–7S
- Escott-Stump S. Nutrition and Diagnois-Related Care. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008
- Sies H (Mar 1997). “Oxidative stress: oxidants and antioxidants”. Experimental Physiology 82 (2): 291-5
- J Clin Endocrinol Metab. 2013 Nov;98(11):4339-45. doi: 10.1210/jc.2012-4287. Epub 2013 Sep 3. Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial. Lehmann U1, Hirche F, Stangl GI, Hinz K, Westphal S, Dierkes J
- Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100-5. [PubMed abstract]
- Heaney RP. (2001). Factors influencing the measurement of bioavailability, taking calcium as a model. Journal of Nutrition 131(suppl):1344S-1348S